glp-1 als Anti-Inflammatory Effects of Receptor Activation in the Brain in Neurodegenerative Diseases Full article: Targeting metabolic dysfunction

Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine

53.9% achieved 5% weight loss with AOM Equally crucial to total weight loss percentage is the proportion of patients achieving clinically meaningful outcomes

Lets explore this

For most patients, the most effective longterm strategy after achieving a target weight is to continue GLP1 treatment

A large share of peptides sold online originate from manufacturers in China, Serbia, and Ukraine

Conclusions: SGLT2i and GLP-1RA were associated with improved survival, cardiovascular, and kidney outcomes with a favorable safety profile